UPL Limited

BSE:512070 Aktierapport

Börsvärde: ₹530.2b

UPL Framtida tillväxt

Future kriterier kontrolleras 3/6

UPL förväntas öka intäkter och intäkter med 29.5% respektive 7.8% per år. EPS förväntas tillväxt med 30.3% per år. Avkastningen på eget kapital förväntas bli 10.8% om 3 år.

Viktig information

29.5%

Tillväxttakt i vinsten

30.34%

Tillväxttakt för EPS

Chemicals vinsttillväxt19.5%
Intäkternas tillväxttakt7.8%
Framtida avkastning på eget kapital10.80%
Bevakning av analytiker

Good

Senast uppdaterad13 May 2026

Senaste uppdateringarna om framtida tillväxt

Recent updates

Uppdatering av berättelse • May 18

512070: Upcoming Governance Meetings Will Support Stronger Medium Term Outlook

Analysts have trimmed their price target on UPL from ₹811.50 to ₹776.22, citing revised assumptions around profit margins, a higher future P/E multiple, and updated views on discount rates and revenue growth. What's in the News UPL has scheduled an Analyst/Investor Day, providing an opportunity to hear directly from management about the business and capital allocation plans.
Uppdatering av berättelse • May 01

512070: Fair Pricing Will Depend On Execution Of Upcoming Restructuring And Treasury Plans

Analysts have trimmed their price target on UPL from ₹647.56 to ₹630.00, citing updated assumptions around revenue growth, profit margin, discount rate and future P/E that slightly adjust their valuation framework. What's in the News UPL has scheduled a Special or Extraordinary Shareholders Meeting on March 31, 2026, at 15:30 IST to consider and approve material related party transactions for sale of materials and functional support services between UPL and its subsidiaries, and between Arysta LifeScience Benelux SRL and UPL Europe Supply Chain GmbH (Key Developments).
Uppdatering av berättelse • Apr 17

512070: Composite Scheme And Governance Steps Will Support Stronger Medium Term Outlook

Analysts have trimmed their price target on UPL slightly from about ₹820.53 to ₹811.50, reflecting updated assumptions around the discount rate, revenue growth, profit margin and future P/E multiple. What's in the News Board meeting on Feb 20, 2026 to consider a Composite Scheme of Arrangement among UPL Limited and multiple group entities under Sections 230 to 232 and 234 of the Companies Act, 2013, based on recommendations from the Audit Committee and the Committee of Independent Directors (company filing).
Uppdatering av berättelse • Apr 03

512070: Upcoming Governance Decisions And Treasury Scheme Will Support A Stronger Outlook

Analysts have trimmed their price target on UPL from ₹975 to ₹947, citing updated assumptions on long term profit margins and P/E multiples, along with refreshed views on growth, discount rates and fair value. What's in the News UPL has called a Special or Extraordinary Shareholders Meeting for March 31, 2026, at 15:30 IST to seek approval for material related party transactions involving sale of materials and functional support services between UPL and its subsidiaries, and between Arysta LifeScience Benelux SRL and UPL Europe Supply Chain GmbH (Key Developments).
Uppdatering av berättelse • Mar 19

512070: Fair Pricing Will Rely On Execution Of Upcoming Restructuring Steps

Analysts have nudged their price target on UPL slightly higher to about ₹648 from roughly ₹641, citing updated assumptions around revenue growth, profit margins, a modestly lower discount rate, and a small adjustment to the expected future P/E multiple. What's in the News UPL has scheduled a board meeting on Feb 02, 2026 at 12:45 Indian Standard Time to consider and approve unaudited consolidated and standalone financial results for the quarter and nine months ended Dec 31, 2025, along with limited review reports from the statutory auditors (Key Developments).
Uppdatering av berättelse • Mar 05

512070: Composite Scheme Board Meeting Will Support Stronger Medium Term Outlook

Analysts have raised their price target on UPL by about ₹39 to ₹820, citing updated assumptions that reflect a slightly lower discount rate, a modest tweak to revenue growth and P/E expectations, and a higher projected profit margin. What's in the News Board meeting scheduled for Feb 20, 2026 at 14:30 IST to consider a Composite Scheme of Arrangement involving UPL and its subsidiaries UPL Sustainable Agri Solutions Limited, UPL Global Sustainable Agri Solutions Limited, and UPL Crop Protection Holdings Limited under Sections 230 to 232 and 234 of the Companies Act, 2013 (company filing).
Uppdatering av berättelse • Feb 18

512070: Revised Margins And Lower P/E Will Likely Struggle To Support Pricing

Analysts have raised their fair value estimate for UPL from ₹600.67 to ₹641.03, citing updated views on the discount rate, revenue growth, profit margins and future P/E assumptions. What's in the News Board meeting scheduled for Feb 02, 2026, at 12:45 Indian Standard Time to review unaudited consolidated and standalone financial results for the quarter and nine months ended Dec 31, 2025 (Key Developments).
Uppdatering av berättelse • Feb 04

512070: Higher Margin Assumptions And Upcoming Results Will Support A Stronger Fair Value Outlook

Analysts have raised their fair value estimate for UPL from ₹944 to ₹975, reflecting updated assumptions around discount rate, revenue growth, profit margin, and future P/E expectations. What's in the News UPL has scheduled a board meeting on Feb 02, 2026, at 12:45 Indian Standard Time to review unaudited consolidated and standalone financial results.
Uppdatering av berättelse • Jan 21

512070: Higher Revenue And Margin Assumptions Will Support A Stronger Fair Value Outlook

Analysts have raised their fair value estimate for UPL from ₹911.93 to ₹944.00 after updating their assumptions for revenue growth, profit margins, discount rate and future P/E. What's in the News UPL has scheduled a Board Meeting on November 6, 2025 to consider and approve the unaudited consolidated and standalone financial results for the quarter and half year ended September 30, 2025, along with the Limited Review Reports from the statutory auditors (company filing).
Uppdatering av berättelse • Jan 07

512070: Small Assumption Tweaks Will Likely Fail To Prevent Margin Pressure

Analysts have slightly increased their fair value estimate for UPL from ₹596.98 to ₹600.67. This reflects small adjustments to assumptions around the discount rate, revenue growth, profit margins and future P/E multiples.
Uppdatering av berättelse • Dec 19

512070: Future Margins Will Likely Deteriorate Despite Higher Market Expectations

Analysts have raised their price target for UPL from approximately 526.51 to 596.98, citing slightly stronger expectations for revenue growth and future valuation multiples, partly offset by a more conservative view on profit margins and discount rates. What's in the News UPL Limited has scheduled a board meeting for November 06, 2025 to consider and approve unaudited consolidated and standalone financial results for the quarter and half year ended September 30, 2025, along with the limited review reports from the statutory auditors (company filing).
Uppdatering av berättelse • Dec 05

512070: Board Meeting And Stable Assumptions Will Shape Medium Term Outlook

Analysts have modestly raised their price target for UPL to ₹781.39, reflecting slightly improved discount rate and future P E assumptions, while largely maintaining their views on growth and profitability. What's in the News A board meeting is scheduled on November 6, 2025 to consider and approve the unaudited consolidated and standalone financial results for the quarter and half year ended September 30, 2025, along with the Statutory Auditors' limited review reports (company filing).
Uppdatering av berättelse • Nov 21

512070: Board Meetings And Adjusted Forecasts Will Influence Medium-Term Outlook

Analysts have raised their price target for UPL from $756.34 to $781.39. This reflects optimism driven by slightly improved revenue growth expectations and adjustments to projected profit margins and valuation multiples.
Uppdatering av berättelse • Nov 07

512070: Upcoming Board Decisions And Steady Financials Will Shape Outlook

Analysts have raised their price target for UPL from $736.09 to $756.34. They cite modest improvements in profit margin and revenue growth forecasts as the reason for this adjustment.
User avatar
Ny berättelse • Dec 10

Biosolutions Innovation And Improved Financial Stability Expected To Boost Earnings Growth

Strategic inventory management and sales mix enhancement are expected to boost margins and improve earnings.

Prognoser för vinst- och omsättningstillväxt

BSE:512070 - Analytikernas framtida uppskattningar och tidigare finansiella data (INR Millions )
DatumIntäkterIntäkterFritt kassaflödeKassaflöde från rörelsenGenomsnittligt Antal analytiker
3/31/2029664,43443,52569,53082,8884
3/31/2028606,42342,45966,95988,60115
3/31/2027568,13734,02350,44869,90913
3/31/2026518,39019,22054,49078,550N/A
12/31/2025490,77016,210N/AN/AN/A
9/30/2025477,15020,53060,52077,890N/A
6/30/2025467,86010,570N/AN/AN/A
3/31/2025466,3707,61083,790100,740N/A
12/31/2024451,420-950N/AN/AN/A
9/30/2024441,220-21,40069,33087,980N/A
6/30/2024432,020-18,860N/AN/AN/A
3/31/2024430,980-13,360-1,73018,220N/A
12/31/2023455,890-5,830N/AN/AN/A
9/30/2023493,81017,2103,88026,540N/A
6/30/2023517,18027,240N/AN/AN/A
3/31/2023535,76034,35053,91077,510N/A
12/31/2022528,68040,360N/AN/AN/A
9/30/2022504,86038,85014,92043,170N/A
6/30/2022485,46037,050N/AN/AN/A
3/31/2022462,40035,05038,08064,960N/A
12/31/2021431,75032,200N/AN/AN/A
9/30/2021410,04030,78024,52046,600N/A
6/30/2021393,76029,070N/AN/AN/A
3/31/2021386,94027,81050,90072,120N/A
12/31/2020370,39024,250N/AN/AN/A
9/30/2020368,05023,39053,29073,610N/A
6/30/2020356,83020,420N/AN/AN/A
3/31/2020357,56017,76067,59087,390N/A
12/31/2019331,40013,650N/AN/AN/A
9/30/2019291,6909,340N/A40,010N/A
6/30/2019256,09011,150N/AN/AN/A
3/31/2019218,37014,910N/A23,560N/A
12/31/2018190,03019,770N/AN/AN/A
9/30/2018182,76020,900N/AN/AN/A
6/30/2018177,89020,590N/AN/AN/A
3/31/2018173,78020,220N/A28,360N/A
12/31/2017170,29020,270N/AN/AN/A
9/30/2017167,54019,120N/AN/AN/A
6/30/2017165,25018,400N/AN/AN/A
3/31/2017163,12017,270N/A25,850N/A
12/31/2016146,18015,473N/AN/AN/A
9/30/2016140,16313,692N/AN/AN/A
6/30/2016135,36613,840N/AN/AN/A
3/31/2016140,4809,400N/A13,960N/A
12/31/2015125,86111,913N/AN/AN/A
9/30/2015125,37011,538N/AN/AN/A
6/30/2015123,97811,347N/AN/AN/A

Analytiker Framtid Tillväxt Prognoser

Intäkter kontra sparande: 512070 s prognostiserade vinsttillväxt ( 29.5% per år) är över sparkvoten ( 6.9% ).

Resultat vs marknad: 512070 s intäkter ( 29.5% per år) förväntas växa snabbare än marknaden för Indian ( 16.3% per år).

Höga tillväxtresultat: 512070 s intäkter förväntas växa avsevärt under de kommande 3 åren.

Intäkt vs marknad: 512070 s intäkter ( 7.8% per år) förväntas växa långsammare än marknaden för Indian ( 10.8% per år).

Hög tillväxtintäkter: 512070 s intäkter ( 7.8% per år) förväntas växa långsammare än 20% per år.

Tillväxtprognoser för vinst per aktie

Framtida avkastning på eget kapital

Framtida ROE: 512070 s avkastning på eget kapital förväntas bli låg om 3 år ( 10.8 %).

Upptäck tillväxtföretag

7D

1Y

7D

1Y

7D

1Y

Företagsanalys och finansiella data Status

UppgifterSenast uppdaterad (UTC-tid)
Analys av företag2026/05/21 09:32
Aktiekurs vid dagens slut2026/05/21 00:00
Intäkter2026/03/31
Årlig intjäning2026/03/31

Datakällor

Den data som används i vår företagsanalys kommer från S&P Global Market Intelligence LLC. Följande data används i vår analysmodell för att generera denna rapport. Data är normaliserade vilket kan medföra en fördröjning från det att källan är tillgänglig.

PaketUppgifterTidsramExempel US-källa
Företagets finansiella ställning10 år
  • Resultaträkning
  • Kassaflödesanalys
  • Balansräkning
Analytikernas konsensusuppskattningar+3 år
  • Prognos för finansiella poster
  • Analytikernas prismål
Marknadspriser30 år
  • Aktiekurser
  • Utdelningar, splittar och åtgärder
Ägarskap10 år
  • Största aktieägare
  • Insiderhandel
Förvaltning10 år
  • Ledningsgrupp
  • Styrelse och verkställande direktörer
Viktiga utvecklingstendenser10 år
  • Företagsmeddelanden

* Exempel för amerikanska värdepapper, för icke-amerikanska värdepapper används motsvarande regelverk och källor.

Om inget annat anges är all finansiell data baserad på en årsperiod men uppdateras kvartalsvis. Detta kallas data för efterföljande tolv månader (TTM) eller senaste tolv månader (LTM). Lär dig mer om detta.

Analysmodell och snöflinga

Detaljer om analysmodellen som användes för att skapa den här rapporten finns på vår Github-sida, vi har också guider om hur du använder våra rapporter och tutorials på Youtube.

Lär dig mer om det team i världsklass som utformade och byggde analysmodellen Simply Wall St.

Industri- och sektormått

Våra bransch- och sektionsmått beräknas var sjätte timme av Simply Wall St, detaljer om vår process finns tillgängliga på Github.

Källor för analytiker

UPL Limited bevakas av 40 analytiker. 17 av dessa analytiker lämnade de uppskattningar av intäkter eller resultat som användes som indata till vår rapport. Analytikernas inskickade estimat uppdateras löpande under dagen.

AnalytikerInstitution
null null360 ONE Capital Market Private Limited
null nullAnand Rathi Shares and Stock Brokers Limited
Himanshu BinaniAnand Rathi Shares and Stock Brokers Limited